• Ending cash balance of $20.3M
• First batch of AKD1500 chips received
• LDA Put Option Agreement expired
• Akida 2.0 licensing agreement with EDGEAI completed
• New hardware platforms planned for AKD1500

BrainChip Holdings Ltd, the world's first commercial producer of neuromorphic artificial intelligence technology, provided the Quarterly Activities Report and Appendix 4C for the quarter ending June 2026. The company reported an ending cash balance of $20.3M, a decrease from $25.3M in the prior quarter. BrainChip received the first production batch of 2,000 units of AKD1500 neuromorphic processors, marking the transition to commercial-scale manufacturing. The company also successfully delivered register-transfer level (RTL) design assets to EDGEAI under the Akida 2.0 licensing agreement. The Put Option Agreement with LDA Capital expired, and the Failure Fee was satisfied through the liquidation of collateral shares. BrainChip plans to allocate more than 2,000 AKD1500 devices to the development of multiple hardware form factors during the second half of 2026. The company continues to make progress on the AKD2500 project and expects to conduct internal demonstrations of the Generative AI platform in the third quarter of 2026.

Ending cash balance of $20.3M, net operating cash outflows of $4.7M

BrainChip enters the second half of 2026 with increasing commercial momentum, supported by production availability of the AKD1500 processor and expansion of its ecosystem.